COVID-19 drove recent leap in preventable respiratory hospitalizations, report says

Hospital admission rates for vaccine-preventable respiratory diseases more than doubled in 2024-2025 versus prepandemic levels, with COVID-19 cited as a major driver. The report points to a worsening public health burden rather than a direct market catalyst. Impact is likely limited to healthcare and public policy sentiment rather than broad financial markets.

Analysis

Hospital admission rates for vaccine-preventable respiratory diseases more than doubled in 2024-2025 versus prepandemic levels, with COVID-19 cited as a major driver. The report points to a worsening public health burden rather than a direct market catalyst. Impact is likely limited to healthcare and public policy sentiment rather than broad financial markets.